103 related articles for article (PubMed ID: 7227980)
1. Studies on the influence of heparin on trypsin-induced shock in dog.
Balldin G; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1981 Mar; 362(3):357-61. PubMed ID: 7227980
[TBL] [Abstract][Full Text] [Related]
2. Trasylol prevents trypsin-induced shock in dogs.
Balldin G; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1979 May; 360(5):651-6. PubMed ID: 89067
[TBL] [Abstract][Full Text] [Related]
3. Influence of plasma protease inhibitors and Trasylol on trypsin-induced bradykinin-release in vitro and in vivo. Protease inhibitors and trypsin-induced bradykinin release.
Balldin G; Gustafsson EL; Ohlsson K
Eur Surg Res; 1980; 12(4):260-9. PubMed ID: 6166477
[TBL] [Abstract][Full Text] [Related]
4. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
Landman H; Markwardt F; Perlewitz J
Thromb Diath Haemorrh; 1969 Dec; 22(3):552-68. PubMed ID: 5382290
[No Abstract] [Full Text] [Related]
5. Modifications in plasma levels of alpha macroglobulins and fibrinogen trypsin perfusion in normal rabbits and in rabbits in acute phase reaction.
Versavel C; Lebreton de Vonne T; Mouray H
Br J Exp Pathol; 1986 Feb; 67(1):65-72. PubMed ID: 2418862
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
[TBL] [Abstract][Full Text] [Related]
7. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
[TBL] [Abstract][Full Text] [Related]
8. [The trypsin-antitrypsin system and the content of blood middle-molecular peptides in experimental traumatic shock].
Gudumak VS; Marchenko VP; Nigulianu VI
Patol Fiziol Eksp Ter; 1990; (2):30-2. PubMed ID: 1696370
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
Finotti P; de Laureto PP
Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulopathy in dogs with shock induced by injection of heartworm extract.
Kitoh K; Watoh K; Kitagawa H; Sasaki Y
Am J Vet Res; 1994 Nov; 55(11):1542-7. PubMed ID: 7879977
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of low molecular weight heparin in a canine model of thromboplastin-induced acute disseminated intravascular coagulation.
Mischke R; Fehr M; Nolte I
Res Vet Sci; 2005 Aug; 79(1):69-76. PubMed ID: 15894027
[TBL] [Abstract][Full Text] [Related]
13. Recombinant antitrypsin Pittsburgh undergoes proteolytic cleavage during E. coli sepsis and fails to prevent the associated coagulopathy in a primate model.
Harper PL; Taylor FB; DeLa Cadena RA; Courtney M; Colman RW; Carrell RW
Thromb Haemost; 1998 Nov; 80(5):816-21. PubMed ID: 9843177
[TBL] [Abstract][Full Text] [Related]
14. Alterations of plasmin activity, plasminogen levels and activity of antiplasmins during endotoxin shock in dogs.
Aasen AO; Gallimore MJ; Ohlsson K; Amundsen E
Haemostasis; 1978; 7(2-3):164-9. PubMed ID: 77807
[TBL] [Abstract][Full Text] [Related]
15. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
Collatos C; Barton MH; Prasse KW; Moore JN
J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
[TBL] [Abstract][Full Text] [Related]
16. Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man.
Hansen JB; Sandset PM; Huseby KR; Huseby NE; Nordøy A
Thromb Haemost; 1996 Nov; 76(5):703-9. PubMed ID: 8950777
[TBL] [Abstract][Full Text] [Related]
17. [Experimental studies on the plasminogen activator and the trypsin inhibitor system in brain tissue in trauma and shock].
Okada Y
Nihon Geka Hokan; 1968 May; 37(3):387-98. PubMed ID: 5748650
[No Abstract] [Full Text] [Related]
18. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Kunitz protease inhibitory domain of the amyloid beta-protein precursor as an anticoagulant in venovenous extracorporeal circulation in rabbits.
Annich G; White T; Damm D; Zhao Y; Mahdi F; Meinhardt J; Rebello S; Lucchesi B; Bartlett RH; Schmaier AH
Thromb Haemost; 1999 Nov; 82(5):1474-81. PubMed ID: 10595641
[TBL] [Abstract][Full Text] [Related]
20. Heparin versus citrate regional anticoagulation during autotransfusion in a porcine intra-abdominal hemorrhage model.
Howdieshell TR; Gay M; DiPiro JT; Mooney S; Duvall R; Eckles S; Baisden R
Am Surg; 1997 Nov; 63(11):1014-8. PubMed ID: 9358794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
